Luo T, Shen W, Zhang C, Song D, Zhang X, Guo A
Database (Oxford). 2025; 2025.
PMID: 40036846
PMC: 11885782.
DOI: 10.1093/database/baaf012.
Seo K, Choi J
Genomics Inform. 2025; 23(1):6.
PMID: 39994831
PMC: 11853700.
DOI: 10.1186/s44342-024-00034-z.
Prazanowska K, Kim T, Kang J, Jin Y, Kwon S, Lim S
Sci Data. 2025; 12(1):177.
PMID: 39885244
PMC: 11782672.
DOI: 10.1038/s41597-025-04510-1.
Mullan K, Ha M, Valkiers S, de Vrij N, Ogunjimi B, Laukens K
Sci Adv. 2024; 10(48):eadr3196.
PMID: 39612336
PMC: 11606500.
DOI: 10.1126/sciadv.adr3196.
Chuang H, Li R, Huang H, Liu S, Wan C, Chaudhuri S
BMC Genomics. 2024; 25(1):1127.
PMID: 39574011
PMC: 11583680.
DOI: 10.1186/s12864-024-11036-0.
A single-cell perspective on immunotherapy for pancreatic cancer: from microenvironment analysis to therapeutic strategy innovation.
Wang R, Liu J, Jiang B, Gao B, Luo H, Yang F
Front Immunol. 2024; 15:1454833.
PMID: 39539544
PMC: 11557317.
DOI: 10.3389/fimmu.2024.1454833.
HTS and scRNA-seq revealed that the location and RSS quality of the mammalian TRBV and TRBJ genes impact biased rearrangement.
Wu Y, Wu F, Ma Q, Li J, Ma L, Zhou H
BMC Genomics. 2024; 25(1):1010.
PMID: 39472808
PMC: 11520388.
DOI: 10.1186/s12864-024-10887-x.
Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens.
Chi W, Hu Y, Huang H, Kuo H, Lin S, Kuo C
J Biomed Sci. 2024; 31(1):94.
PMID: 39379923
PMC: 11463125.
DOI: 10.1186/s12929-024-01082-x.
T-cell clones of uncertain significance. When is the rogue clone dangerous?.
Semenzato G, Teramo A, Calabretto G, Zambello R
Haematologica. 2024; 110(1):37-46.
PMID: 39363880
PMC: 11694120.
DOI: 10.3324/haematol.2024.286023.
Application and research progress of single cell sequencing technology in leukemia.
Xie D, An B, Yang M, Wang L, Guo M, Luo H
Front Oncol. 2024; 14:1389468.
PMID: 39267837
PMC: 11390353.
DOI: 10.3389/fonc.2024.1389468.
Multi-omics analysis of SIV-specific CD8+ T cells in multiple anatomical sites.
Simpson J, Dulek B, Schaughency P, Brenchley J
PLoS Pathog. 2024; 20(9):e1012545.
PMID: 39250524
PMC: 11412524.
DOI: 10.1371/journal.ppat.1012545.
Measuring single-cell immune clonality to track haematological cancers.
Choo A, Tuong Z
Clin Transl Med. 2024; 14(8):e1780.
PMID: 39162183
PMC: 11333942.
DOI: 10.1002/ctm2.1780.
The reverse TRBV30 gene of mammals: a defect or superiority in evolution?.
Wu F, Wu Y, Yao Y, Xu Y, Peng Q, Ma L
BMC Genomics. 2024; 25(1):705.
PMID: 39030501
PMC: 11264764.
DOI: 10.1186/s12864-024-10632-4.
A general pHLA-CD80 scaffold fusion protein to promote efficient antigen-specific T cell-based immunotherapy.
Wu Y, Liang X, Sun Y, Ning J, Dai Y, Jin S
Mol Ther Oncol. 2024; 32(3):200827.
PMID: 39027379
PMC: 11255371.
DOI: 10.1016/j.omton.2024.200827.
Self-supervised learning of T cell receptor sequences exposes core properties for T cell membership.
Kabeli R, Zevin S, Abargel A, Zilberberg A, Efroni S
Sci Adv. 2024; 10(17):eadk4670.
PMID: 38669334
PMC: 11809652.
DOI: 10.1126/sciadv.adk4670.
Identification of apolipoprotein B-reactive CDR3 motifs allows tracking of atherosclerosis-related memory CD4T cells in multiple donors.
Roy P, Suthahar S, Makings J, Ley K
Front Immunol. 2024; 15:1302031.
PMID: 38571941
PMC: 10988780.
DOI: 10.3389/fimmu.2024.1302031.
Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy.
Tan C, Lindner K, Boschert T, Meng Z, Rodriguez Ehrenfried A, De Roia A
Nat Biotechnol. 2024; 43(1):134-142.
PMID: 38454173
PMC: 11738991.
DOI: 10.1038/s41587-024-02161-y.
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia.
Serio B, Giudice V, Selleri C
Medicina (Kaunas). 2023; 59(12).
PMID: 38138273
PMC: 10744863.
DOI: 10.3390/medicina59122170.
Early predictive factors of failure in autologous CAR T-cell manufacturing and/or efficacy in hematologic malignancies.
Baguet C, Larghero J, Mebarki M
Blood Adv. 2023; 8(2):337-342.
PMID: 38052048
PMC: 10788849.
DOI: 10.1182/bloodadvances.2023011992.
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells.
Li J, Xiao Z, Wang D, Jia L, Nie S, Zeng X
Mol Cancer. 2023; 22(1):141.
PMID: 37649123
PMC: 10466891.
DOI: 10.1186/s12943-023-01844-5.